As of Oct 18
| -1.09 / -5.72%|
The 1 analysts offering 12-month price forecasts for Acer Therapeutics Inc have a median target of 10.36, with a high estimate of 10.36 and a low estimate of 10.36. The median estimate represents a -42.18% decrease from the last price of 17.91.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.